You have free access to this content

Hepatology

Cover image for Vol. 60 Issue 1

July 2014

Volume 60, Issue 1

Pages 1–443

  1. Hepatology Highlights

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Hepatology highlights (pages 1–3)

      Jean-François Dufour

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.27226

  2. Master's Perspective

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
  3. Editorials

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
      Platelet-derived serotonin: Translational implications for liver regeneration (pages 30–33)

      Mickaël Lesurtel and Pierre-Alain Clavien

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.27067

    7. You have free access to this content
  4. Rapid Communication

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
  5. Viral Hepatitis

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China (pages 46–55)

      Mehlika Toy, Joshua A. Salomon, Hao Jiang, Honglian Gui, Hui Wang, Jiangshe Wang, Jan Hendrik Richardus and Qing Xie

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26934

    2. You have free access to this content
      All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection (pages 56–64)

      David L. Wyles, Maribel Rodriguez-Torres, Eric Lawitz, Mitchell L. Shiffman, Stanislas Pol, Robert W. Herring, Benedetta Massetto, Bittoo Kanwar, James D. Trenkle, Phil S. Pang, Yanni Zhu, Hongmei Mo, Diana M. Brainard, G. Mani Subramanian, John G. McHutchison, François Habersetzer and Mark S. Sulkowski

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27053

    3. You have free access to this content
      Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C (pages 65–76)

      Julien Vergniol, Jérôme Boursier, Clélia Coutzac, Sandrine Bertrais, Juliette Foucher, Camille Angel, Faiza Chermak, Isabelle Fouchard Hubert, Wassil Merrouche, Frédéric Oberti, Victor de Lédinghen and Paul Calès

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.27069

    4. You have free access to this content
      Distinct seromarkers predict different milestones of chronic hepatitis B progression (pages 77–86)

      Jessica Liu, Hwai-I Yang, Mei-Hsuan Lee, Richard Batrla-Utermann, Chin-Lan Jen, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Chuhsing Kate Hsiao, Chien-Jen Chen and for the R.E.V.E.A.L.-HBV Study Group

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27083

    5. You have free access to this content
      Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta (pages 87–97)

      Benjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, Boris A. Ratsch, Kalliopi Zachou, Birgit Bremer, George N. Dalekos, Andreas Erhardt, Fehmi Tabak, Kendal Yalcin, Selim Gürel, Stefan Zeuzem, Markus Cornberg, C.-Thomas Bock, Michael P. Manns, Heiner Wedemeyer and for the HIDIT-1 Study Group

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.27102

    6. You have free access to this content
      HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV (pages 98–105)

      Fasiha Kanwal, Jennifer R. Kramer, Jawad Ilyas, Zhigang Duan and Hashem B. El-Serag

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.27095

    7. You have free access to this content
      Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project (pages 106–113)

      Blanca Sampedro, Cándido Hernández-López, José Ramón Ferrandiz, Aitziber Illaro, Emilio Fábrega, Antonio Cuadrado, Paula Iruzubieta, Susana Menéndez, Joaquín Cabezas and Javier Crespo

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27103

    8. You have free access to this content
    9. You have free access to this content
  6. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis (pages 133–145)

      Priya Handa, Bryan D. Maliken, James E. Nelson, Vicki Morgan-Stevenson, Donald J. Messner, Barjinderjit K. Dhillon, Heather M. Klintworth, Mary Beauchamp, Matthew M. Yeh, Clinton T. Elfers, Christian L. Roth and Kris V. Kowdley

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26946

    2. You have free access to this content
      Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice (pages 146–157)

      Hyo-Jung Kwon, Young-Suk Won, Ogyi Park, Binxia Chang, Michael J. Duryee, Geoffrey E. Thiele, Akiko Matsumoto, Surendra Singh, Mohamed A. Abdelmegeed, Byoung-Joon Song, Toshihiro Kawamoto, Vasilis Vasiliou, Geoffrey M. Thiele and Bin Gao

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27036

    3. You have free access to this content
      Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes (pages 158–168)

      David J. Harman, Philip V. Kaye, Rebecca Harris, Ayako Suzuki, Anastasios Gazis and Guruprasad P. Aithal

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27098

    4. You have free access to this content
      High-fat diet triggers Mallory-Denk body formation through misfolding and crosslinking of excess keratin 8 (pages 169–178)

      Ozlem Kucukoglu, Nurdan Guldiken, Yu Chen, Valentyn Usachov, Amin El-Heliebi, Johannes Haybaeck, Helmut Denk, Christian Trautwein and Pavel Strnad

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.27068

  7. Hepatobiliary Malignancies

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Blockade of CD47-mediated cathepsin S/protease-activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma (pages 179–191)

      Terence Kin-Wah Lee, Vincent Chi-Ho Cheung, Ping Lu, Eunice Yuen Ting Lau, Stephanie Ma, Kwan Ho Tang, Man Tong, Jessica Lo and Irene Oi Lin Ng

      Version of Record online: 29 MAY 2014 | DOI: 10.1002/hep.27070

    2. You have free access to this content
      Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology-pathology correlation and survival of radiation segmentectomy (pages 192–201)

      Michael Vouche, Ali Habib, Thomas J. Ward, Edward Kim, Laura Kulik, Daniel Ganger, Mary Mulcahy, Talia Baker, Michael Abecassis, Kent T. Sato, Juan-Carlos Caicedo, Jonathan Fryer, Ryan Hickey, Elias Hohlastos, Robert J. Lewandowski and Riad Salem

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.27057

  8. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge (pages 202–210)

      Yoo-Mee Vanwijngaerden, Lies Langouche, Richard Brunner, Yves Debaveye, Marijke Gielen, Michael Casaer, Christopher Liddle, Sally Coulter, Pieter J. Wouters, Alexander Wilmer, Greet Van den Berghe and Dieter Mesotten

      Version of Record online: 26 FEB 2014 | DOI: 10.1002/hep.26928

    2. You have free access to this content
      Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease (pages 211–223)

      Kazuhiko Bessho, Reena Mourya, Pranavkumar Shivakumar, Stephanie Walters, John C. Magee, Marepalli Rao, Anil G. Jegga and Jorge A. Bezerra

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.27045

    3. You have free access to this content
      Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice (pages 224–236)

      Aki Ikeda, Nobuhiro Aoki, Masahiro Kido, Satoru Iwamoto, Hisayo Nishiura, Ryutaro Maruoka, Tsutomu Chiba and Norihiko Watanabe

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27087

  9. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis (pages 237–249)

      Yoon Seok Roh, Surim Park, Jong Won Kim, Chae Woong Lim, Ekihiro Seki and Bumseok Kim

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26981

    2. You have free access to this content
      Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures (pages 250–256)

      Jasmohan S. Bajaj, Jacqueline G. O'Leary, K. Rajender Reddy, Florence Wong, Scott W. Biggins, Heather Patton, Michael B. Fallon, Guadalupe Garcia-Tsao, Benedict Maliakkal, Raza Malik, Ram M. Subramanian, Leroy R. Thacker, Patrick S. Kamath and on behalf of the North American Consortium for the Study of End-stage Liver Disease (NACSELD)

      Version of Record online: 29 MAY 2014 | DOI: 10.1002/hep.27077

  10. Liver Injury/Regeneration

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans (pages 257–266)

      Patrick Starlinger, Alice Assinger, Stefanie Haegele, David Wanek, Silvia Zikeli, Dominic Schauer, Peter Birner, Edith Fleischmann, Birgit Gruenberger, Christine Brostjan and Thomas Gruenberger

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.26950

    2. You have free access to this content
      Plasmacytoid dendritic cell-derived IFN-α promotes murine liver ischemia/reperfusion injury by induction of hepatocyte IRF-1 (pages 267–277)

      Antonino Castellaneta, Osamu Yoshida, Shoko Kimura, Shinichiro Yokota, David A. Geller, Noriko Murase and Angus W. Thomson

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.27037

    3. You have free access to this content
      Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury (pages 278–289)

      Branden D. Tarlow, Milton J. Finegold and Markus Grompe

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27084

    4. You have free access to this content
      Suppression of autophagy during liver regeneration impairs energy charge and hepatocyte senescence in mice (pages 290–300)

      Takeo Toshima, Ken Shirabe, Takasuke Fukuhara, Toru Ikegami, Tomoharu Yoshizumi, Yuji Soejima, Tetsuo Ikeda, Shinji Okano and Yoshihiko Maehara

      Version of Record online: 6 MAY 2014 | DOI: 10.1002/hep.27140

  11. Liver Biology/Pathobiology

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease (pages 301–310)

      Muriel Girard, Florence Lacaille, Virginie Verkarre, Raphael Mategot, Gerard Feldmann, Alain Grodet, Frédérique Sauvat, Sabine Irtan, Anne Davit-Spraul, Emmanuel Jacquemin, Frank Ruemmele, Dominique Rainteau, Olivier Goulet, Virginie Colomb, Christophe Chardot, Alexandra Henrion-Caude and Dominique Debray

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26974

    2. You have free access to this content
      Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury (pages 311–322)

      Ingrid Lua, David James, Jiaohong Wang, Kasper S. Wang and Kinji Asahina

      Version of Record online: 28 APR 2014 | DOI: 10.1002/hep.27035

    3. You have free access to this content
      Ring1B promotes hepatic stem/progenitor cell expansion through simultaneous suppression of Cdkn1a and Cdkn2a in mice (pages 323–333)

      Hiroyuki Koike, Yasuharu Ueno, Takako Naito, Tomoya Shiina, Susumu Nakata, Rie Ouchi, Yuta Obana, Keisuke Sekine, Yun-Wen Zheng, Takanori Takebe, Kyo-ichi Isono, Haruhiko Koseki and Hideki Taniguchi

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.27046

    4. You have free access to this content
      Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis (pages 334–348)

      Michaela Granzow, Robert Schierwagen, Sabine Klein, Benita Kowallick, Sebastian Huss, Markus Linhart, Irela G. Reza Mazar, Jan Görtzen, Annabelle Vogt, Frank A. Schildberg, Maria A. Gonzalez-Carmona, Alexandra Wojtalla, Benjamin Krämer, Jacob Nattermann, Sören V. Siegmund, Nikos Werner, Dieter O. Fürst, Wim Laleman, Percy Knolle, Vijay H. Shah, Tilman Sauerbruch and Jonel Trebicka

      Version of Record online: 6 MAY 2014 | DOI: 10.1002/hep.27117

    5. You have free access to this content
      Reversal of hepatocyte senescence after continuous in vivo cell proliferation (pages 349–361)

      Min-Jun Wang, Fei Chen, Jian-Xiu Li, Chang-Cheng Liu, Hai-Bin Zhang, Yong Xia, Bing Yu, Pu You, Dao Xiang, Lian Lu, Hao Yao, Uyunbilig Borjigin, Guang-Shun Yang, Kirk J. Wangensteen, Zhi-Ying He, Xin Wang and Yi-Ping Hu

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27094

  12. AASLD Practice Guideline

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
  13. Reviews

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Pruritus in cholestasis: Facts and fiction (pages 399–407)

      Ulrich Beuers, Andreas E. Kremer, Ruth Bolier and Ronald P.J. Oude Elferink

      Version of Record online: 29 MAY 2014 | DOI: 10.1002/hep.26909

    2. You have free access to this content
      The architecture of diagnostic research: From bench to bedside—research guidelines using liver stiffness as an example (pages 408–418)

      Agostino Colli, Mirella Fraquelli, Giovanni Casazza, Dario Conte, Dimitrinka Nikolova, Piergiorgio Duca, Kristian Thorlund and Christian Gluud

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.26948

  14. Hepatology Elsewhere

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
    2. You have free access to this content
  15. Clinical Observations in Hepatology

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Treatment of acute portal vein thrombosis by nontraditional anticoagulation (pages 425–426)

      Melissa Martinez, Anand Tandra and Raj Vuppalanchi

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26998

  16. Correspondence

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis (pages 428–429)

      Danny Issa, Naim Alkhouri, Cynthia Tsien, Shetal Shah, Rocio Lopez, Arthur McCullough and Srinivasan Dasarathy

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26908

      Corrected by:

      Correction: Correction

      Vol. 62, Issue 4, 1330, Version of Record online: 30 JUL 2015

    4. You have free access to this content
      Reply (pages 429–430)

      Ho Cheol Hong and Kyung Mook Choi

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26906

    5. You have free access to this content
      Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib (page 430)

      Ciprian Tomuleasa, Gianluigi Giannelli, Andrei Cucuianu, Mihaela Aldea, Angelo Paradiso and Ioana Berindan-Neagoe

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26907

    6. You have free access to this content
      Neurocognitive function and dysfunction after hepatitis C therapy (page 431)

      Pablo Solis-Muñoz, Carlos Mingote-Adán and Jose Antonio Solís-Herruzo

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26919

    7. You have free access to this content
      Reply (pages 431–432)

      Arne Schäfer, Michael R. Kraus and Michael Scheurlen

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.26918

    8. You have free access to this content
      Liver stiffness changes during meal times (page 432)

      Jun Liong Chin, Angelina Farrelly, Grace Chan, Suzanne Norris and P. Aiden McCormick

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.26922

  17. OWN White Paper

    1. Top of page
    2. Hepatology Highlights
    3. Master's Perspective
    4. Editorials
    5. Rapid Communication
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Biliary Disease
    10. Liver Failure/Cirrhosis/Portal Hypertension
    11. Liver Injury/Regeneration
    12. Liver Biology/Pathobiology
    13. AASLD Practice Guideline
    14. Reviews
    15. Hepatology Elsewhere
    16. Clinical Observations in Hepatology
    17. Correspondence
    18. OWN White Paper
    1. You have free access to this content
      Entrustable professional activities for gastroenterology fellowship training (pages 433–443)

      Suzanne Rose, Oren K. Fix, Brijen J. Shah, Tamara N. Jones and Ronald D. Szyjkowski

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.27238

SEARCH

SEARCH BY CITATION